Immunovant logo

Immunovant Share Price Today (NASDAQ: IMVT)

Immunovant share price is $15.63 & ₹1,345.20 as on 14 Jun 2025, 01.29 hrs IST

$15.63

-0.31

(-1.94%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Immunovant share price in Dollar and Rupees. Guide to invest in Immunovant stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunovant, along with analyst recommendations, forecasts, and comprehensive financials.

Immunovant share price movements

  • Today's Low: $15.36
    Today's High: $15.92

    Day's Volatility :3.52%

  • 52 Weeks Low: $12.72
    52 Weeks High: $34.47

    52 Weeks Volatility :63.1%

Immunovant (IMVT) Returns

PeriodImmunovant IncSector (Health Care)Index (Russel 2000)
3 Months
-21.9%
-6.1%
0.0%
6 Months
-43.41%
-3.4%
0.0%
1 Year
-39.87%
-6.7%
0.0%
3 Years
353.19%
13.0%
3.6%

Immunovant (IMVT) Key Statistics

in dollars & INR

Previous Close
$15.94
Open
$15.92
Today's High
$15.92
Today's Low
$15.36
Market Capitalization
$2.8B
Today's Volume
$1.1M
52 Week High
$34.47
52 Week Low
$12.72
Revenue TTM
$0.0
EBITDA
$-437.8M
Earnings Per Share (EPS)
$-2.63
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-62.46%

How to invest in Immunovant Stock (IMVT) from India?

It is very easy for Indian residents to invest directly in Immunovant from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunovant stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunovant or IMVT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunovant or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunovant shares which would translate to 0.055 fractional shares of Immunovant as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Immunovant, in just a few clicks!

Returns in Immunovant (IMVT) for Indian investors in Rupees

The Immunovant stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunovant investment value today

Current value as on today

₹63,154

Returns

₹36,846

(-36.85%)

Returns from Immunovant Stock

₹39,885 (-39.88%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Immunovant (IMVT)

-44%

Period: May 14, 2025 to Jun 13, 2025. Change in 30 Days versus previous period

Search interest for Immunovant Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Immunovant

  • FMR Inc

    10.09%

  • Deep Track Capital, LP

    5.56%

  • Vanguard Group Inc

    4.06%

  • T. Rowe Price Investment Management,Inc.

    3.45%

  • Baker Bros Advisors LP

    3.19%

  • BlackRock Inc

    3.14%

Analyst Recommendation on Immunovant

Rating
Trend

Buy

    95%Buy

    4%Hold

    0%Sell

Based on 22 Wall street analysts offering stock ratings for Immunovant(by analysts ranked 0 to 5 stars)

Analyst Forecast on Immunovant Stock (IMVT)

What analysts predicted

Upside of 180.03%

Target:

$43.77

Current:

$15.63

Insights on Immunovant Stock (Ticker Symbol: IMVT)

  • Price Movement

    In the last 3 years, IMVT stock has moved up by 354.5%
  • IMVT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 131.6%

Immunovant Technicals Summary

Sell

Neutral

Buy

Immunovant is currently in a neutral trading position according to technical analysis indicators.

Immunovant (IMVT) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Immunovant Inc logo
12.32%
-43.41%
-39.87%
353.19%
-39.0%
Regeneron Pharmaceuticals, Inc. logo
-9.61%
-27.05%
-48.98%
-5.77%
-10.46%
Beone Medicines Ltd logo
19.44%
52.93%
65.87%
97.21%
57.25%
Vertex Pharmaceuticals Incorporated logo
4.88%
-2.68%
-5.24%
79.7%
70.13%
Alnylam Pharmaceuticals, Inc. logo
8.48%
26.01%
91.68%
126.98%
139.48%

Immunovant Dividend announcements

  • Immunovant Earnings

    Immunovant’s price-to-earnings ratio stands at None

About Immunovant

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for graves' disease and thyroid eye disease. The company has a license agreement with HanAll Biopharma Co., Ltd. for the rights of intellectual property relating to IMVT-1402 and batoclimab. Immunovant, Inc. was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Organization
Immunovant
Employees
362
CEO
Dr. Eric Venker M.D., Pharm.D.
Industry
Finance

Management People of Immunovant

NameTitle
Dr. Frank M. Torti M.B.A., M.D.
Executive Chairperson of the Board
Dr. Eric Venker M.D., Pharm.D.
CEO & Director
Dr. Jay S. Stout Ph.D.
Chief Technology Officer
Mr. Tiago M. Girao CPA
Chief Financial Officer
Ms. Melanie Gloria B.S.N.
Chief Operating Officer
Mr. Christopher A. Van Tuyl Esq., J.D.
Chief Legal Officer & Corporate Secretary
Ms. Lauren Schrier M.B.A.
Vice President of Marketing
Ms. Christine Blodgett
Senior Vice President of Human Resources
Mr. Andy Deig
Senior Vice President of Strategic Finance
Dr. Michael Geffner M.B.A., M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in IMVT Stock from India :

Can Indians buy Immunovant shares?

Yes, Indians can invest in the Immunovant (IMVT) from India.

With INDmoney, you can buy Immunovant at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Immunovant at zero transaction cost.

How can I buy Immunovant shares from India?

It is very easy to buy Immunovant from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunovant (IMVT) be purchased?

Yes, you can buy fractional shares of Immunovant with INDmoney app.

What are the documents required to start investing in Immunovant stocks?

To start investing in Immunovant, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Immunovant share price today?

Immunovant share price today stands at $15.63, Open: $15.92 ; Previous Close: $15.94 ; High: $15.92 ; Low: $15.36 ; 52 Week High: $34.47 ; 52 Week Low: $12.72.

The stock opens at $15.92, after a closing price of $15.94. The stock reached a daily high of $15.92 and a low of $15.36, with a 52-week high of $34.47 and a 52-week low of $12.72.

What are today’s High and Low prices of Immunovant Stock (IMVT)?

Today’s highest price of Immunovant (IMVT) is $15.92.

Today’s lowest price of Immunovant (IMVT) is $15.36.

What is the 52 Week High and Low Range of Immunovant Stock (IMVT)?

  • 52 Week High

    $34.47

  • 52 Week Low

    $12.72

What are the historical returns of Immunovant (IMVT)?

  • 1 Month Returns

    12.32%

  • 3 Months Returns

    -43.41%

  • 1 Year Returns

    -39.87%

  • 5 Years Returns

    -39%

What is today's market capitalisation of Immunovant?

Today's market capitalisation of Immunovant IMVT is 2.8B

Who is the Chief Executive Officer (CEO) of Immunovant ?

Dr. Eric Venker M.D., Pharm.D. is the current Chief Executive Officer (CEO) of Immunovant.